No Data
Stocks News Premium = Support for resolving "Drug Loss", marking related Stocks with support for clinical trials of new drugs overseas.
To resolve the 'drug loss' issue, which prevents the use of new drugs approved overseas but not in Japan, the government will support early commercialization through clinical trial assistance. There is a desire to mark related stocks. <M&A is also frequent> In Japan, the time until new drugs are approved is relatively long, and due to issues such as clinical trial costs and profitability, overseas Drug Manufacturers may not aim to enter. Many new drugs in this state of drug loss exist, and patient groups are seeking improvements.
Linical To Go Ex-Dividend On March 28th, 2025 With 16 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Linical(2183.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 16 JPY dividend per share. The ex-dividend
Linical Revises Fiscal Forecast Amid Global Challenges, Records Tax Gain
Linical Reports Decline in Financial Performance for 2024
Linical Co Sees FY Loss Y570.00M
Linical: Supplementary explanation of financial results for the 3rd quarter of the fiscal year ending March 31, 2025
